Steindl, Ariane
Schlieter, Franziska
Klikovits, Thomas
Leber, Elena
Gatterbauer, Brigitte
Frischer, Josa M.
Dieckmann, Karin
Widhalm, Georg
Zöchbauer-Müller, Sabine
Hoda, Mir Ali Reza
Preusser, Matthias
Berghoff, Anna S. http://orcid.org/0000-0001-9379-6797
Funding for this research was provided by:
Daiichi-Sankyo (UE71101084)
Article History
Received: 1 July 2019
Accepted: 21 August 2019
First Online: 27 August 2019
Compliance with ethical standards
:
: Anna Sophie Berghoff has research support from Daiichi Sankyo and honoraria for lectures, consultation or advisory board participation from Roche Bristol-Myers Squibb, Merck, Daiichi Sankyo as well as travel support from Roche, Amgen and AbbVie. Matthias Preusser has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Merck Sharp & Dome. All other authors report no conflicts of interest.
: The study was approved by the ethics committee of the Medical University of Vienna (vote 078/2004) and performed in accordance with the Declaration of Helsinki.